← FDA Drug Approvals (Drugs@FDA)

GANZYK-RTU

NDA · New Drug Application · Sponsor: EXELA PHARMA · Approved 2017-02-17

Drug application

FDA Application #

NDA209347

Application type

New Drug Application

Brand name

GANZYK-RTU

Generic name

Ganciclovir

Active ingredients

GANCICLOVIR

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

EXELA PHARMA

First approval

2017-02-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown